BLFS BioLife Solutions, Inc. logo

BLFS BioLife Solutions, Inc.

Healthcare
$23.95-3.19%ClosedMarket Cap: $1.17B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

3.12

P/S

11.73

EV/EBITDA

-155.79

DCF Value

$-4.53

FCF Yield

-0.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

63.9%

Operating Margin

-10.9%

Net Margin

-10.5%

ROE

-2.9%

ROA

-2.6%

ROIC

-2.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$27.5M$1.2M$
Q4 null$18.8M$3.5M$
FY null$96.2M$-12.1M$
Q3 null$28.1M$621.0K$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$34.00

Target (Median)

$34.00

Target Range

$34.00 - $34.00

1 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell
HC Wainwright & Co.Buy
2025-12-29
HC Wainwright & Co.Buy
2025-11-24
HC Wainwright & Co.Buy
2025-08-08

Trading Activity

Insider Trades

View All
Casdin Partners Master Fund, L.P.10 percent owner
SellThu May 21
Casdin Partners Master Fund, L.P.10 percent owner
SellThu May 21
Casdin Partners Master Fund, L.P.10 percent owner
SellThu May 21
Wichterman Troyofficer: Chief Financial Officer
SellFri Apr 10
Mathew Aby J.officer: EVP & Chief Scientific Officer
SellFri Apr 10

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

1.97

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.

Peers